Placeholder Banner

BIO Comments to FDA on Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products

August 3, 2023

In response to the agency's request for information (Docket No. FDA-2023-N-0743-0002), BIO provides detailed comments.

Download Full Comments Below
BIO Comment Letter - FDA-2023-N-0743
Discover More
BIO provides detailed comments in advance of the July 31, 2023 NIH Workshop, “Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer.
In response to a Request for Information (RFI) from the Senate 340B Bipartisan Working Group, BIO submitted detailed comments on the current status of the program and suggestions for improvements.